emerging tech investing Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030
medical device investing Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025
medical device investing Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)
